Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Payables (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Payables for 5 consecutive years, with $29.0 million as the latest value for Q4 2025.

  • Quarterly Payables rose 855.19% to $29.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.0 million through Dec 2025, up 855.19% year-over-year, with the annual reading at $29.0 million for FY2025, 855.19% up from the prior year.
  • Payables for Q4 2025 was $29.0 million at Werewolf Therapeutics, up from $7.1 million in the prior quarter.
  • The five-year high for Payables was $29.0 million in Q4 2025, with the low at $986000.0 in Q1 2025.
  • Average Payables over 5 years is $4.5 million, with a median of $2.1 million recorded in 2021.
  • Peak annual rise in Payables hit 855.19% in 2025, while the deepest fall reached 92.56% in 2025.
  • Over 5 years, Payables stood at $2.0 million in 2021, then plummeted by 40.06% to $1.2 million in 2022, then skyrocketed by 555.45% to $8.0 million in 2023, then crashed by 62.08% to $3.0 million in 2024, then soared by 855.19% to $29.0 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $29.0 million, $7.1 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.